// App-Quantinova.ai

561 : Real-world use of first-line chemotherapy in post-menopausal patients with HR-positive HER2-negative metastatic breast cancer (mBC) in a US community oncology network.

Researchers

Presenter

  • Debra A. Patt

Principal Investigators

  • Xiaolong Jiao

  • Eileen Fonseca

  • Jamyia Clark

  • Patricia S. Fox

  • Ruslan Horblyuk

  • Lynn McRoy

  • Jack Mardekian

  • Bhakti Arondekar

Medical Centers

  • The US Oncology Network/McKesson Specialty Health, The Woodlands, TX

  • Pfizer Inc, New York, NY

Locations

  • United States

Companies

  • PharmAbcine Inc.

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

Biomarkers

  • Human epidermal growth factor receptor 2

  • Hormone receptor

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved